Company: BKR
Filing Date: 2025-03-31
Form Type: 8-K
Source: 0001193125-25-067691
Chunk: 0

Company: Baker Hughes Co
Filing Date: 2025-03-31
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item 5.02      Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.  

On March 28, 2025, Lynn L. Elsenhans informed Baker Hughes Company (the “ Company”) that she will not stand for re-electionat the Company’s upcoming 2025 Annual Meeting of Shareholders (the “2025 Annual Meeting”). Ms. Elsenhans has served as a member of the Board of Directors of the Company (the “ Board”) since 2019 and previously served as a member of the Board of Directors of the Company’s predecessor entities Baker Hughes Incorporated and Baker Hughes GE from 2012-2017 and 2017-2019, respectively. Ms. Elsenhans currently serves as the chair of the Governance & Corporate Responsibility Committee and a member of the Human Capital and Compensation Committee. Ms. Elsenhans will continue to serve in her committee roles until May 1, 2025 and as a director until the 2025 Annual Meeting. Ms. Elsenhans’ decision not to stand for re-electionat the 2025 Annual Meeting is not the result of any disagreement with the Company. The Board sincerely thanks Ms. Elsenhans for her significant contributions to the Company and wishes her every success in her future endeavors.

On March 28, 2025, the Board elected Ilham Kadri to serve as a director of the Company with a term beginning on May 1, 2025. Effective May 1, 2025, the size of the Board will be expanded from ten to eleven members.

Ilham Kadri, age 56, has served as Chief Executive Officer of Syensqo S. A. since December 2023, when the Solvay Group separated into two distinct companies: Solvay S. A. and Syensqo S. A. Prior to this separation, Dr. Kadri was Chief Executive Officer of Solvay S. A. from 2019 to December 2023. Prior to Solvay S. A., she was Chief Executive Officer and President of Diversey, Inc., having led the company’s spin off and divestiture to Bain Capital. Dr. Kadri has extensive leadership experience across a variety of industries on four continents and with leading industrial multinationals, including Shell plc, UCB, Huntsman Corporation, Dow Chemical Company and Sealed Air Corporation. Dr. Kad